arrow
S

So-Young Park

chungang university
H指数:29
被引数:3,416

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Circulating 1-Methylnicotinamide Predicts Dupilumab Response in Adult Asthma: A Prediction Model

1-甲基烟酰胺循环水平预测Dupilumab对成人哮喘的疗效:一项预测模型

2026-05-060
PRE
Asthma remission and its predictors in severe asthma: real-world study from the Korean severe asthma registry

重度哮喘的缓解及其预测因素:来自韩国重度哮喘登记研究的真实世界研究

2025-12-270
OAAI
Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancer

囊泡介导的线粒体清除在 triple-negative breast cancer 中呈现出可操作性的代谢脆弱性

2025-12-160
OAAI
Type 2 Biomarkers as Mediators of Clinical Remission With Biologics in Severe Asthma
2025-12-010
PRE
Reply to “Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time”

回复“嗜酸性哮喘研究中优化FeNO和血嗜酸性粒细胞分层:调整吸烟史和采血时间”

2025-11-150
PRE
Impact of Biologics on Nasal Symptoms in Severe Asthmatics: Findings From the PRISM Study
2025-11-011
PRE
Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma Study

重度哮喘中嗜酸性粒细胞和FeNO作为生物疗法的指标:来自“重度哮喘中的精准医学干预研究”的结果

2025-03-180
PRE
Relationships Between Chronic Cough and Asthma Control and Quality of Life in Patients With Severe Asthma: A 6-Month Longitudinal Analysis
2025-01-010
PRE
Serum and urine eosinophil-derived neurotoxin (EDN) levels predict biologic response in severe asthma

血清和尿液中嗜酸性粒细胞衍生神经毒素(EDN)水平可预测重度哮喘的生物制剂治疗反应

2025-01-010
PRE
Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment

2型生物制剂治疗重度嗜酸性粒细胞哮喘的纵向多轨迹表型

2024-12-010
OAAI
Artificial intelligence-based evaluation of carotid artery compressibility via point-of-care ultrasound in determining the return of spontaneous circulation during cardiopulmonary resuscitation

基于人工智能的通过实时超声评估颈动脉可压缩性,以确定心肺复苏期间的自主循环恢复

2024-09-011
OAAI
Effect of biologic therapies on quality of life in severe asthma Findings from the PRISM study
2024-09-010
OAAI